Davidson Capital Management’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
Other funds holding ABBV
Davidson Capital Management's ABBV Position: Q3 2026 in Review
Davidson Capital Management opened a new position in AbbVie (ABBV) in Q3 2026: 16,272 shares worth $4.26M. The stake represents 0.7% of the portfolio and ranks #43 among its holdings. This is a return to the name: Davidson Capital Management previously reported a position in ABBV as recently as Q4 2023.
Davidson Capital Management first reported a position in ABBV in Q1 2021 and has held it in 11 quarters since. 1,958 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.
- Davidson Capital Management held 16,272 shares of AbbVie worth $4.26M as of Q3 2026.
- AbbVie was a new Davidson Capital Management position in Q3 2026.
- AbbVie made up 0.7% of Davidson Capital Management's portfolio in Q3 2026, its #43 holding.
- Davidson Capital Management first reported a position in AbbVie in Q1 2021 and has held it in 11 quarters since.
- 1,958 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.
Based on Davidson Capital Management's 13F filing for Q3 2026, filed 15 Oct 2026.